Sofinnova
Sofinnova holds EUR 150m close for third biotech fund
Impact fund has made two investments as of its interim close and expects to make 10-12 in total
Consortium backs €38.75m series-B for Tissium
France-based wound dressing developer previously raised €30.5m at the series-A stage
French GPs opt for organic diversification
Recent fund closes show that organic diversification is still a valid option for some GPs and VCs willing to step out of their comfort zones
Sofinnova et al. invest €20m in Afyren
France-based biotech business Afyren plans to commercialise its products in 2020
Sofinnova et al. back €27m series-C for Limflow
BPI France and Balestier, a Singaporean family fund, also take part in the financing
Sofinnova closes biotech fund on $650m hard-cap
Fund's different generations have received a combined $2bn of committments in total
Sofinnova leads €22.5m Gecko Biomedical round
Extension to series-A round also includes BPI France, Omnes, CM-CIC Innovation and CapDecisif
Sofinnova and Imperial's Mission Therapeutics raises £60m
Investment led by Woodford Patient Capital Trust and saw existing backers re-up
Sofinnova et al. in €72.8m series-C round for Merus
Third largest round observed by unquote" in Benelux so far in 2015
VC backers divest GlycoVaxyn to GSK
Deal values biopharmaceutical company at $212m
VC-backed Ascendis raises $108m in IPO
Listing priced at $18 per share
Ascendis completes $60m series-D
A total of seven investors comitted capital to the round
Auris’ delayed IPO lists below initial price range
Number of shares on offer increased by more than 35% but price almost halved
Sofinnova-backed Auris announces price range
Float expected to be worth between £69-82m
VC-backed OpenERP raises $10m
Company to rebrand as Odoo as part of the deal
Sofinnova leads CHF 32m round for ObsEva
Sofinnova Partners has led a CHF 32m series-A round for Swiss biopharma company ObsEva.
European venture: patience rewarded
Patience rewarded
Idinvest leads €34m round for Crocus
Idinvest Partners has led a €34m funding round for Crocus Technology, a French supplier of magnetic semiconductors and sensors, with participation from a consortium of new and existing backers.
Emerald Technology Ventures et al. back MetGen
Emerald Technology Ventures and several other backers have invested in a series-A financing round for MetGen Oy, a Finnish industrial biotech company.
CDC Entreprises and Sofinnova invest €8m in MedDay
CDC Entreprises and Sofinnova Partners have made an €8m equity investment in French biotech firm MedDay.
Aledia raises €10m in first funding round
Sofinnova Partners, Braemar Energy Ventures, Demeter Partners and CEA Investissement have participated in a €10m funding round for French LED developer Aledia.
CDC leads €10m round for McPhy Energy
CDC Entreprises has invested €5m as part of a €10m round for French hydrogen storage specialist McPhy Energy.
Venture's Olympic performance
Venture's Olympic performance
Declining activity belies venture successes
Although European venture capital activity decreased by 12% to €974m last year, 2011 saw a number of sizeable fund closes as well strong exits, indicating fresh appetite for the asset class.